Abstract |
Although progressive multifocal leukoencephalopathy (PML) cases showing responses to mefloquine therapy have been reported, the efficacy of mefloquine for PML remains unclear. We report on the failure of mefloquine therapy in two Japanese patients with PML unrelated to human immunodeficiency virus. One of the patients was a 47-year-old male who had been treated with chemotherapy for Waldenström macroglobulinemia, and the other was an 81-year-old male with idiopathic CD4(+) lymphocytopenia. Diagnosis of PML was established based on MRI findings and increased JC virus DNA in the cerebrospinal fluid in both patients. Mefloquine was initiated about 5 months and 2 months after the onset of PML, respectively. During mefloquine therapy, clinical and radiological progression was observed, and JC virus DNA in the cerebrospinal fluid was increased in both patients. Both patients died about 4 months and 2 months after initiation of mefloquine, respectively. Further studies are necessary to clarify the differences between mefloquine responders and non-responders in PML.
|
Authors | Zen Kobayashi, Miho Akaza, Yoshiyuki Numasawa, Shoichiro Ishihara, Hiroyuki Tomimitsu, Kazuo Nakamichi, Masayuki Saijo, Tomohiro Morio, Norio Shimizu, Nobuo Sanjo, Shuzo Shintani, Hidehiro Mizusawa |
Journal | Journal of the neurological sciences
(J Neurol Sci)
Vol. 324
Issue 1-2
Pg. 190-4
(Jan 15 2013)
ISSN: 1878-5883 [Electronic] Netherlands |
PMID | 23182496
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 Elsevier B.V. All rights reserved. |
Chemical References |
- Antibodies, Monoclonal, Murine-Derived
- DNA, Viral
- Immunosuppressive Agents
- Rituximab
- Mefloquine
|
Topics |
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived
(therapeutic use)
- Apraxias
(etiology)
- Asian People
- Brain
(pathology)
- DNA, Viral
(genetics)
- Gait Disorders, Neurologic
(etiology)
- Gene Dosage
- Humans
- Immunosuppressive Agents
(therapeutic use)
- JC Virus
- Leukoencephalopathy, Progressive Multifocal
(drug therapy, virology)
- Magnetic Resonance Imaging
- Male
- Mefloquine
(therapeutic use)
- Middle Aged
- Muscle Cramp
(etiology)
- Paresis
(etiology)
- Rituximab
- Treatment Failure
|